Dr Frank Veith explains the advantage of MDs and industry working together to create innovative products and improve education while criticizing regulations that restrict the MD/industry relationship.

Does the Mole Always Come Before the Melanoma?

Sep 15th, 2017 58s

Dr Arefa Cassoobhoy highlights one of the week's important news stories for primary care.

Pediatrics Will Keep You Young

Aug 29th, 2017 5m 25s

Dr Alok Patel meets with a 12-year-old expert to explore the latest tween craze.

What Do Doctors Really Think About the ACA?

Jun 20th, 2017

Physicians from all over the country tell Medscape about their experiences with the ACA. What's your take?

Biomarkers to Determine Who Gets Checkpoint Inhibitors

Apr 3rd, 2017 5m 11s

Reviewing recent research, Dr Jeffrey Weber concludes that an amalgam of host- and tumor-related markers will be the best indication of which patients should receive checkpoint inhibitors.

Findings From NEMO, and Other Melanoma Highlights

May 31st, 2016 5m 40s

In a preview of ASCO melanoma studies, the NEMO results suggest that binimetinib is reasonable for NRAS-mutated melanoma, and combo regimens continue to show strong outcomes, reports Dr Jeffrey Weber.

Melanoma: ‘Tail’ on Survival Curve Is Getting Longer

Apr 28th, 2016 2m 31s

Dr Jeffrey Weber, Medscape's new commentator on melanoma and immunotherapy, discusses impressive data on overall survival and combination therapy presented at AACR 2016.

Rapper, Internist ZDoggMD on the 'Hard Doc's Life'

Nov 16th, 2015 21m 51s

Zubin Damania, an internist and rapper/singer who performs musical parodies under the name ZDoggMD, talks with Eric Topol about his love for Weird Al and his novel medical practice, Turntable Health.

Rashes: Critical Dermatology Issues in Primary Care

Oct 29th, 2015 25m 7s

In Part 1 of Critical Issues in Dermatology, Drs Charles Vega and Graeme Lipper discuss some common dermatologic conditions and how to best manage them.

Emperor's Mukherjee on the Three Laws of Medicine

Oct 12th, 2015 29m 53s

Eric Topol speaks with author Siddhartha Mukherjee about his latest book, The Laws of Medicine, and how uncertainty, imperfections, priors, outliers, and biases affect these laws.

CDC Head Answers Your Questions on Antibiotic Resistance

May 14th, 2015 9m 42s

When the Antibiotic Resistance National Action Plan was announced, our readers had many concerns and questions. We asked CDC Director Tom Frieden for answers.

Antibiotics, Resistance, and Learning From Ebola

Sep 18th, 2014

WebMD's Hansa Bhargava asks CDC's Tom Frieden to comment on current issues in infectious diseases and the changing microbial landscape.

You Can Help Prevent Skin Cancer

Sep 3rd, 2014

New resources, such as behavioral intervention counseling, can help you convince your patients to take steps to prevent skin cancer.

Could This Rash Mean Malignancy?

Aug 19th, 2014

Jonathan Kay describes a patient with an extensive rash that initially suggested dermatomyositis but turned out to auger something more serious.

'Pretty Darn Impressive' PD-1 Data in Melanoma

Jun 12th, 2014

Drs. Antoni Ribas and Jeffrey Weber discuss the exceptional data for melanoma in immuno- and targeted therapies presented at ASCO 2014.

Dalbavancin: New Option for Skin, Skin Structure Infections

May 23rd, 2014

Dalbavancin -- a new agent in the crowded gram-positive field -- offers advantages when issues arise with compliance or if long-term venous access isn't practical. Dr. Auwaerter offers perspective.

Mukherjee on Practicing Oncology, the Pulitzer, and New Book

Apr 23rd, 2014

Medscape Editor-in-Chief Eric J. Topol, MD, talks with Siddhartha Mukherjee, MD, PhD, about his career as a researcher and doctor, winning the Pulitzer Prize, and the topic for his next book.

NYC's Top Doc on Bloomberg's Controversial Health Mandates

Dec 18th, 2013

Under the leadership of Dr. Thomas Farley, New York City and Mayor Michael Bloomberg have implemented some of the toughest health laws in the nation.

Creative Disruption? She's 29 and Set to Reboot Lab Medicine

Nov 18th, 2013

A 29-year-old Stanford dropout has developed a new biotechnology that threatens to give laboratory medicine its biggest shakeup in decades.

FDA's Hamburg on Clearing the Hurdles to Drug Approvals

Oct 17th, 2013

FDA Commissioner Margaret Hamburg, MD, talks with Medscape at the National Health Research Forum in Washington, DC.

Ipilimumab Goes the Distance in Melanoma Survival

Oct 8th, 2013

Drs. Antoni Ribas and Caroline Robert discuss hallmark melanoma findings in targeted therapies, immunotherapy, and combination therapies presented at ECC 2013.